IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v17y2020i12p4456-d374412.html
   My bibliography  Save this article

An Exploratory Research of 18 Years on the Economic Burden of Diabetes for the Romanian National Health Insurance System

Author

Listed:
  • Claudiu Morgovan

    (Preclinical Department, Faculty of Medicine, “Lucian Blaga” University of Sibiu, 2A Lucian Blaga St., 550169 Sibiu, Romania
    These authors contributed equally to this work.)

  • Smaranda Adina Cosma

    (Department of Hospitality Services, Faculty of Business, “Babeș-Bolyai” University, 7 Horea St., 400174 Cluj-Napoca, Romania
    These authors contributed equally to this work.)

  • Madalina Valeanu

    (Department of Medical Informatics and Biostatistics, Faculty of Medicine, “Iuliu Haţieganu” University Medicine and Pharmacy, 4 Louis Pasteur St., 400349 Cluj-Napoca, Romania)

  • Anca Maria Juncan

    (Preclinical Department, Faculty of Medicine, “Lucian Blaga” University of Sibiu, 2A Lucian Blaga St., 550169 Sibiu, Romania)

  • Luca Liviu Rus

    (Preclinical Department, Faculty of Medicine, “Lucian Blaga” University of Sibiu, 2A Lucian Blaga St., 550169 Sibiu, Romania)

  • Felicia Gabriela Gligor

    (Preclinical Department, Faculty of Medicine, “Lucian Blaga” University of Sibiu, 2A Lucian Blaga St., 550169 Sibiu, Romania)

  • Anca Butuca

    (Preclinical Department, Faculty of Medicine, “Lucian Blaga” University of Sibiu, 2A Lucian Blaga St., 550169 Sibiu, Romania)

  • Delia Mirela Tit

    (Department of Pharmacy, University of Oradea, 29 Nicolae Jiga St., 410028 Oradea, Romania
    These authors contributed equally to this work.)

  • Simona Bungau

    (Department of Pharmacy, University of Oradea, 29 Nicolae Jiga St., 410028 Oradea, Romania
    These authors contributed equally to this work.)

  • Steliana Ghibu

    (Department of Pharmacology, Physiology and Pathophysiology, Faculty of Pharmacy, “Iuliu Haţieganu” University Medicine and Pharmacy, 4 Louis Pasteur St., 400349 Cluj-Napoca, Romania)

Abstract

The prevalence of diabetes mellitus (DM) rises constantly each year worldwide. Because of that, the funds allocated for the DM treatment have increased over time. Regarding the number of DM cases, Romania is among the top ten countries in Europe. Based on the National Diabetes Programme (NDP), antidiabetic drugs and other expenditures (Self-monitoring blood glucose (SMBG) test, HbA1c, insulin pumps/insulin pumps supplies) are free of charge. This programme has undergone many changes in drugs supply, in the last two decades: re-organizing the NDP, authorization of new molecules with high prices (e.g., SGLT-2 inhibitors, etc.) or new devices (e.g., insulin pumps, etc.) The main purpose of this study is to identify and analyse the impact of the DM costs on the Romanian health budget and to highlight the evolution of these costs. A retrospective longitudinal research on the official data regarding the DM costs from 2000 to 2017 was performed. The DM funds (DMF) were adjusted with the inflation rate. In this period, the average share of DMF in the total funds allocated for health programmes was 21.3 ± 3.4%, and DMF average growth rate was 25.4% (r = 0.488, p = 0.047). On the other hand, the DMF increased more than 14 times, in spite of the patients’ number having increased only about 2.5 times. Referring to the structure of DMF, the mean value of the antidiabetic drugs cost was of 96,045 ± 67,889 thousand EUR while for other expenditures it was of 11,530 ± 7922 thousand EUR (r = 0.945, p < 0.001). Between 2008 and 2017, the total DMF was 181,252 ± 74,278 thousand EUR/year. Moreover, the average patients’ number was 667,384 ± 94,938 (r = 0.73, p = 0.016), and the cost of treatment was 215 ± 36 EUR/patient/year. Even if the cost is rising, the correct and optimal treatment is a main condition for the diabetic patient’s health and for the prevention of its complications, which have multiple socio-economic repercussions.

Suggested Citation

  • Claudiu Morgovan & Smaranda Adina Cosma & Madalina Valeanu & Anca Maria Juncan & Luca Liviu Rus & Felicia Gabriela Gligor & Anca Butuca & Delia Mirela Tit & Simona Bungau & Steliana Ghibu, 2020. "An Exploratory Research of 18 Years on the Economic Burden of Diabetes for the Romanian National Health Insurance System," IJERPH, MDPI, vol. 17(12), pages 1-16, June.
    • Handle: RePEc:gam:jijerp:v:17:y:2020:i:12:p:4456-:d:374412
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/17/12/4456/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/17/12/4456/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Grégoire Lagasnerie & Anne-Sophie Aguadé & Pierre Denis & Anne Fagot-Campagna & Christelle Gastaldi-Menager, 2018. "The economic burden of diabetes to French national health insurance: a new cost-of-illness method based on a combined medicalized and incremental approach," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(2), pages 189-201, March.
    2. Smaranda Adina Cosma & Marius Bota & Cristina Fleșeriu & Claudiu Morgovan & Mădălina Văleanu & Dan Cosma, 2020. "Measuring Patients’ Perception and Satisfaction with the Romanian Healthcare System," Sustainability, MDPI, vol. 12(4), pages 1-16, February.
    3. Bernard Charbonnel & Dominique Simon & Jean Dallongeville & Isabelle Bureau & Sylvie Dejager & Laurie Levy-Bachelot & Julie Gourmelen & Bruno Detournay, 2018. "Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database Analysis," PharmacoEconomics - Open, Springer, vol. 2(2), pages 209-219, June.
    4. Michelle Quarti Machado Rosa & Roger Dos Santos Rosa & Marcelo G. Correia & Denizar V. Araujo & Luciana R. Bahia & Cristiana M. Toscano, 2018. "Disease and Economic Burden of Hospitalizations Attributable to Diabetes Mellitus and Its Complications: A Nationwide Study in Brazil," IJERPH, MDPI, vol. 15(2), pages 1-17, February.
    5. Andrei Cătălin Muntean & Claudiu Morgovan & Smaranda Cosma & Smaranda Cosma & Anca Butucă & Anca Maria Juncan & Luca Liviu Rus & Andreea Loredana Vonica & Felicia Gabriela Gligor & Steliana Ghibu, 2019. "Study Of Life Quality And Treatment Satisfaction Of Romanian Diabetic Patients," CBU International Conference Proceedings, ISE Research Institute, vol. 7(0), pages 771-777, September.
    6. Till Seuring & Olga Archangelidi & Marc Suhrcke, 2015. "The Economic Costs of Type 2 Diabetes: A Global Systematic Review," PharmacoEconomics, Springer, vol. 33(8), pages 811-831, August.
    7. Kyu-Tae Han & Geum Joon Cho & Eui Hyeok Kim, 2018. "Evaluation of the Association between Gestational Diabetes Mellitus at First Pregnancy and Cancer within 10 Years Postpartum Using National Health Insurance Data in South Korea," IJERPH, MDPI, vol. 15(12), pages 1-9, November.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Qian Xing & Wenxi Tang & Mingyang Li & Shuailong Li, 2022. "Has the Volume-Based Drug Purchasing Approach Achieved Equilibrium among Various Stakeholders? Evidence from China," IJERPH, MDPI, vol. 19(7), pages 1-22, April.
    2. Zhigang Guo & Lin Bai & Zhenhuan Luo & Mengyuan Fu & Liguang Zheng & Xiaodong Guan & Luwen Shi, 2021. "Factors Associated with Free Medicine Use in Patients with Hypertension and Diabetes: A 4-Year Longitudinal Study on Full Coverage Policy for Essential Medicines in Taizhou, China," IJERPH, MDPI, vol. 18(22), pages 1-10, November.
    3. Cornelia Bala & Adriana Rusu & Dana Ciobanu & Gabriela Roman, 2022. "Length of Hospital Stay, Hospitalization Costs, and Their Drivers in Adults with Diabetes in the Romanian Public Hospital System," IJERPH, MDPI, vol. 19(16), pages 1-13, August.
    4. Diana I. Sima & Cosmina I. Bondor & Ioan A. Vereşiu & Norina A. Gâvan & Cristina M. Borzan, 2021. "Hospitalization Costs of Lower Limb Ulcerations and Amputations in Patients with Diabetes in Romania," IJERPH, MDPI, vol. 18(5), pages 1-11, February.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. J. Pöhlmann & K. Norrbacka & K. S. Boye & W. J. Valentine & H. Sapin, 2020. "Costs and where to find them: identifying unit costs for health economic evaluations of diabetes in France, Germany and Italy," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(8), pages 1179-1196, November.
    2. Clara Bermudez-Tamayo & Stéphane Besançon & Mira Johri & Sidibe Assa & Jonathan Betz Brown & Kaushik Ramaiya, 2017. "Direct and indirect costs of diabetes mellitus in Mali: A case-control study," PLOS ONE, Public Library of Science, vol. 12(5), pages 1-14, May.
    3. Haruhisa Fukuda & Shunya Ikeda & Takeru Shiroiwa & Takashi Fukuda, 2016. "The Effects of Diagnostic Definitions in Claims Data on Healthcare Cost Estimates: Evidence from a Large-Scale Panel Data Analysis of Diabetes Care in Japan," PharmacoEconomics, Springer, vol. 34(10), pages 1005-1014, October.
    4. Seuring, Till & Serneels, Pieter & Suhrcke, Marc & Bachmann, Max, 2020. "Diabetes, employment and behavioural risk factors in China: Marginal structural models versus fixed effects models," Economics & Human Biology, Elsevier, vol. 39(C).
    5. Elina Jussila & Kaisa Kotakorpi & Jouko Verho, 2022. "Prescription Behavior of Physicians in the Public and Private Sector," CESifo Working Paper Series 10186, CESifo.
    6. David Cuesta-Frau & Daniel Novák & Vacláv Burda & Daniel Abasolo & Tricia Adjei & Manuel Varela & Borja Vargas & Milos Mraz & Petra Kavalkova & Marek Benes & Martin Haluzik, 2019. "Influence of Duodenal–Jejunal Implantation on Glucose Dynamics: A Pilot Study Using Different Nonlinear Methods," Complexity, Hindawi, vol. 2019, pages 1-10, February.
    7. Rättö, Hanna & Kurko, Terhi & Martikainen, Jaana E. & Aaltonen, Katri, 2021. "The impact of a co-payment increase on the consumption of type 2 antidiabetics – A nationwide interrupted time series analysis," Health Policy, Elsevier, vol. 125(9), pages 1166-1172.
    8. Clémence Bussière & Nicolas Sirven & Thomas Rapp & Christine Sevilla‐Dedieu, 2020. "Adherence to medical follow‐up recommendations reduces hospital admissions: Evidence from diabetic patients in France," Health Economics, John Wiley & Sons, Ltd., vol. 29(4), pages 508-522, April.
    9. Gourzoulidis, George & Kourlaba, Georgia & Stafylas, Panagiotis & Giamouzis, Gregory & Parissis, John & Maniadakis, Nikolaos, 2017. "Association between copayment, medication adherence and outcomes in the management of patients with diabetes and heart failure," Health Policy, Elsevier, vol. 121(4), pages 363-377.
    10. François-Olivier Baudot & Anne-Sophie Aguadé & Thomas Barnay & Christelle Gastaldi-Ménager & Anne Fagot-Campagna, 2019. "Impact of type 2 diabetes on health expenditure: estimation based on individual administrative data," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(5), pages 657-668, July.
    11. Isabelle Chort & Olivier Dagnelie, 2022. "Worms or sugar? Mass deworming treatment doubles the probability to suffer from diabetes ten to fifteen years later," Working papers of Transitions Energétiques et Environnementales (TREE) hal-03887621, HAL.
    12. Seuring, Till & Serneels, Pieter & Suhrcke, Marc, 2019. "The impact of diabetes on labour market outcomes in Mexico: A panel data and biomarker analysis," Social Science & Medicine, Elsevier, vol. 233(C), pages 252-261.
    13. Luz María Peña-Longobardo & Isaac Aranda-Reneo & Juan Oliva-Moreno & Svenja Litzkendorf & Isabelle Durand-Zaleski & Eduardo Tizzano & Julio López-Bastida, 2020. "The Economic Impact and Health-Related Quality of Life of Spinal Muscular Atrophy. An Analysis across Europe," IJERPH, MDPI, vol. 17(16), pages 1-12, August.
    14. Adela Laura Popa & Naiana Nicoleta Ţarcă & Dinu Vlad Sasu & Simona Aurelia Bodog & Remus Dorel Roşca & Teodora Mihaela Tarcza, 2022. "Exploring Marketing Insights for Healthcare: Trends and Perspectives Based on Literature Investigation," Sustainability, MDPI, vol. 14(17), pages 1-21, August.
    15. Rodríguez-Sánchez, Beatriz & Cantarero-Prieto, David, 2019. "Socioeconomic differences in the associations between diabetes and hospital admission and mortality among older adults in Europe," Economics & Human Biology, Elsevier, vol. 33(C), pages 89-100.
    16. Michael Ekholuenetale & Anthony Ike Wegbom & Clement Kevin Edet & Charity Ehimwenma Joshua & Amadou Barrow & Chimezie Igwegbe Nzoputam, 2023. "Impact of Chronic Diseases on Labour Force Participation among South African Women: Further Analysis of Population-Based Data," World, MDPI, vol. 4(1), pages 1-12, February.
    17. Muhammad Daoud Butt & Siew Chin Ong & Muhammad Umar Wahab & Muhammad Fawad Rasool & Fahad Saleem & Adnan Hashmi & Ahsan Sajjad & Furqan Aslam Chaudhry & Zaheer-Ud-Din Babar, 2022. "Cost of Illness Analysis of Type 2 Diabetes Mellitus: The Findings from a Lower-Middle Income Country," IJERPH, MDPI, vol. 19(19), pages 1-15, October.
    18. Kurubaran Ganasegeran & Chee Peng Hor & Mohd Fadzly Amar Jamil & Hong Chuan Loh & Juliana Mohd Noor & Norshahida Abdul Hamid & Purnima Devi Suppiah & Mohd Rizal Abdul Manaf & Alan Swee Hock Ch’ng & Ir, 2020. "A Systematic Review of the Economic Burden of Type 2 Diabetes in Malaysia," IJERPH, MDPI, vol. 17(16), pages 1-23, August.
    19. Juan Carlos Caro & Pourya Valizadeh & Alejandrina Correa & Andres Silva & Shu Wen Ng, 2020. "Combined fiscal policies to promote healthier diets: Effects on purchases and consumer welfare," PLOS ONE, Public Library of Science, vol. 15(1), pages 1-23, January.
    20. Ling Jie Cheng & Wenru Wang & Suan Tee Lim & Vivien Xi Wu, 2019. "Factors associated with glycaemic control in patients with diabetes mellitus: A systematic literature review," Journal of Clinical Nursing, John Wiley & Sons, vol. 28(9-10), pages 1433-1450, May.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:17:y:2020:i:12:p:4456-:d:374412. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.